Empower Clinics Partners With MediPro To Sell COVID-19 Test Kits In Canada

Empower Clinics (CSE: CBDT) this morning announced that it has secured a medical device establishment license (MDEL). The status enables the firm to sell its KAI Saliva COVID-19 PCR test kits within Canada.

The MDEL status effectively enables the company to import, distribute, and sell KAI Saliva test kits, as part of its focus on the ongoing pandemic. The saliva test kits reportedly are approved for FDA EUA use, while also containing the CE Mark, enabling the sale of the test kits in the European Union, while also being approved by Health Canada.

The kit is reportedly specifically geared towards use for travelers, enabling a means of obtaining and conducting an RT-PCR test prior to arriving or coming back to Canada, or other regions that have similar travel requirements. The kit is reportedly focused on providing a home-based, self-administered test to make it travel easier for its users.

Cambria Gold Mines — sponsored Sponsored · Cambria Gold Mines

The company has partnered with MediPro Canada to use their approved MDEL status for the sale of the test kits. While the company has applied for its own MDEL, the company in the interim appears to be going through MediPro to enable the generation of sales until it receives its own license.

Financial aspects of the arrangement were not provided.

Empower Clinics last traded at $0.48 on the CSE.


Information for this briefing was found via Sedar, and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Is Agnico Eagle Seabridge Gold’s Mystery Lender?

This Gold Giant Is Building 1.5 Million More Ounces a Year | Agnico Eagle Q3 Earnings

This Gold Giant Was a Mess. Now It’s Back! | Barrick Mining Q3 2026 Earnings

Recommended

Epic Gold Delivers Maiden 279,000 Ounce Inferred Resource at Wilson Project

First Phosphate Adds UK Export Finance to Growing Export Credit Lineup With C$220 Million Letter of Interest

Related News

Empower Closes $3.0 Million Financing, CEO Enters Into Share Loan Arrangement

Empower Clinics (CSE: CBDT) has evidently closed a much-needed financing as of last night. The...

Friday, January 7, 2022, 08:56:18 AM

Empower Clinics Eyes Selling Sun Valley Cannabis Assets Back To Founders For US$1 Million

Empower Clinics Inc. (CSE: CBDT) announced today that it has signed a non-binding term sheet...

Wednesday, July 21, 2021, 08:29:00 AM

Empower Clinics Enters Strategic Review After Cancelling Financing

Empower Clinics (CSE: EPW), a once-popular healthcare name among investors that provided diagnostic testing during...

Tuesday, March 21, 2023, 08:29:32 AM

Empower Clinics Raises Further $1.5 Million From Warrant Exercises, Receives License From Health Canada

Empower Clinics (CSE: CBDT) this morning released a company update covering numerous topics, including recent...

Friday, March 19, 2021, 08:28:21 AM

Empower Clinics Posts Q1 Revenues Of $2.0 Million, Net Loss Of $25.2 Million

Empower Clinics (CSE: CBDT) this morning reported its first quarter financial results for the period...

Wednesday, July 14, 2021, 08:20:47 AM